| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |